<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Phc Holdings Corp. — News on 6ix</title>
    <link>https://6ix.com/company/phc-holdings-corp</link>
    <description>Latest news and press releases for Phc Holdings Corp. on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Tue, 01 Jul 2025 05:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/phc-holdings-corp" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d62d42beedb30cb6fc7ffe.webp</url>
      <title>Phc Holdings Corp.</title>
      <link>https://6ix.com/company/phc-holdings-corp</link>
    </image>
    <item>
      <title>PHC Announces Exclusive Distribution of MaxCyte® ExPERT™ Platform in Japan</title>
      <link>https://6ix.com/company/phc-holdings-corp/news/phc-announces-exclusive-distribution-of-maxcyter-experttm-platform-in-japan-1</link>
      <guid isPermaLink="true">https://6ix.com/company/phc-holdings-corp/news/phc-announces-exclusive-distribution-of-maxcyter-experttm-platform-in-japan-1</guid>
      <pubDate>Tue, 01 Jul 2025 05:00:00 GMT</pubDate>
      <description>TOKYO, July 01, 2025--The Biomedical Division of PHC Corporation (Headquarters: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura; hereafter referred to as &quot;PHCbi&quot;), a subsidiary of PHC Holdings Corporation (Headquarters: Chiyoda-ku, Tokyo, hereafter referred to as &quot;PHCHD&quot;) announces it has signed an exclusive agreement with MaxCyte, Inc. to distribute the MaxCyte ExPERT platform(*1) in Japan. In Singapore, SciMed (Asia) Pte Ltd, a subsidiary of PHCHD, separately entered into an exclusive distribut</description>
    </item>
  </channel>
</rss>